Literature DB >> 20541584

Selective cell death in neurodegeneration: why are some neurons spared in vulnerable regions?

K L Double1, S Reyes, E L Werry, G M Halliday.   

Abstract

Neurodegenerative diseases exhibit varying and characteristic patterns of regional brain cell death, yet in each disorder there are distinct variations in the relative vulnerability of neurons within targeted brain regions. For example, in Parkinson's disease (PD) up to 90% of dopaminergic neurons of the ventral tier of the substantia nigra pars compacta are lost at post-mortem, while as few as 25% of dopaminergic neurons in the dorsal tier of this nucleus succumb to the disease process. To date the reasons underlying differential vulnerability of similar neurons within a defined cytoarchitectural region has received little attention. We suggest variations in protein distribution underlies this differential vulnerability. Within the substantia nigra pars compacta the more vulnerable neurons exhibit an increased expression of factors that may contribute to vulnerability (D(2) dopamine autoreceptors, GIRK-2 potassium channels, lactotransferrin and the dopamine transporter) while also expressing a relative lack of neuroprotective elements (dopamine vesicle transport protein and a number of trophic and growth factors). Differential distribution of key proteins expressed by individual cells within the same cytoarchitectural brain region may influence the severity and likelihood of common neurodegenerative mechanisms, such as protein aggregation, oxidative stress, neuroinflammation and apoptosis, and thus the eventual fate of individual cells in the disease process. An understanding of how variable protein expression can influence cell survival within the diseased human brain in a range of neurodegenerative disorders may provide avenues for the development of novel strategies to improve the survival of targeted neurons in vivo.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20541584     DOI: 10.1016/j.pneurobio.2010.06.001

Source DB:  PubMed          Journal:  Prog Neurobiol        ISSN: 0301-0082            Impact factor:   11.685


  41 in total

1.  Circuit-Specific Early Impairment of Proprioceptive Sensory Neurons in the SOD1G93A Mouse Model for ALS.

Authors:  Soju Seki; Toru Yamamoto; Kiara Quinn; Igor Spigelman; Antonios Pantazis; Riccardo Olcese; Martina Wiedau-Pazos; Scott H Chandler; Sharmila Venugopal
Journal:  J Neurosci       Date:  2019-09-17       Impact factor: 6.167

2.  Particulate matter neurotoxicity in culture is size-dependent.

Authors:  Patricia Gillespie; Julianne Tajuba; Morton Lippmann; Lung-Chi Chen; Bellina Veronesi
Journal:  Neurotoxicology       Date:  2011-10-25       Impact factor: 4.294

3.  Location and Number of Astrocytes Determine Dopaminergic Neuron Survival and Function Under 6-OHDA Stress Mediated Through Differential BDNF Release.

Authors:  Indrani Datta; Kavina Ganapathy; Rema Razdan; Ramesh Bhonde
Journal:  Mol Neurobiol       Date:  2017-09-30       Impact factor: 5.590

4.  HIV-1 Tat regulation of dopamine transmission and microglial reactivity is brain region specific.

Authors:  Douglas R Miller; Fatemeh Shaerzadeh; Leah Phan; Nesrin Sharif; Joyonna Gamble-George; Jay P McLaughlin; Wolfgang J Streit; Habibeh Khoshbouei
Journal:  Glia       Date:  2018-05-07       Impact factor: 7.452

5.  Complex Changes in the Innate and Adaptive Immunity Accompany Progressive Degeneration of the Nigrostriatal Pathway Induced by Intrastriatal Injection of 6-Hydroxydopamine in the Rat.

Authors:  Giulia Ambrosi; Natasa Kustrimovic; Francesca Siani; Emanuela Rasini; Silvia Cerri; Cristina Ghezzi; Giuseppe Dicorato; Sofia Caputo; Franca Marino; Marco Cosentino; Fabio Blandini
Journal:  Neurotox Res       Date:  2017-03-11       Impact factor: 3.911

Review 6.  Opportunities and challenges of pluripotent stem cell neurodegenerative disease models.

Authors:  Jackson Sandoe; Kevin Eggan
Journal:  Nat Neurosci       Date:  2013-06-25       Impact factor: 24.884

7.  Exosomes-associated neurodegeneration and progression of Parkinson's disease.

Authors:  Isabella Russo; Luigi Bubacco; Elisa Greggio
Journal:  Am J Neurodegener Dis       Date:  2012-11-18

Review 8.  Mesencephalic and extramesencephalic dopaminergic systems in Parkinson's disease.

Authors:  Fanni F Geibl; Martin T Henrich; Wolfgang H Oertel
Journal:  J Neural Transm (Vienna)       Date:  2019-01-14       Impact factor: 3.575

Review 9.  Insulin-Like Growth Factor-II/Cation-Independent Mannose 6-Phosphate Receptor in Neurodegenerative Diseases.

Authors:  Y Wang; R G MacDonald; G Thinakaran; S Kar
Journal:  Mol Neurobiol       Date:  2016-03-19       Impact factor: 5.590

Review 10.  The endocannabinoid system in normal and pathological brain ageing.

Authors:  Andras Bilkei-Gorzo
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-12-05       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.